Maryam Panahiazar

Dr. Maryam Panahiazar


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
ASAfshin Shoeibi
Afshin Shoeibi
MKMarjaneh Khodatars
Marjaneh Khodatars
NGNavid Ghassemi
Navid Ghassemi
MJMahboobeh Jafari
Mahboobeh Jafari
PMParisa Moridian
Parisa Moridian
U Rajendra AcharyaU Rajendra Acharya
U Rajendra Acharya
A variety of screening approaches have been proposed to diagnose epileptic seizures, using electroencephalography (EEG) and magnetic resonance imaging (MRI) modalities. Artificial intelligence encompasses a variety of areas, and one of its branches is deep learning (DL). Before the rise of DL, conventional machine learning algorithms involving feature extraction were performed. This limited their performance to the ability of those handcrafting the features. However, in DL, the extraction of features and classification are entirely automated. The advent of these techniques in many areas of medicine, such as in the diagnosis of epileptic seizures, has made significant advances. In this study, a comprehensive overview of works focused on automated epileptic seizure detection using DL techniques and neuroimaging modalities is presented. Various methods proposed to diagnose epileptic seizures automatically using EEG and MRI modalities are described. In addition, rehabilitation systems developed for epileptic seizures using DL have been analyzed, and a summary is provided. The rehabilitation tools include cloud computing techniques and hardware required for implementation of DL algorithms. The important challenges in accurate detection of automated epileptic seizures using DL with EEG and MRI modalities are discussed. The advantages and limitations in employing DL-based techniques for epileptic seizures diagnosis are presented. Finally, the most promising DL models proposed and possible future works on automated epileptic seizure detection are delineated.

23 October 2019 in Scientific Data
Verified
Journal Article
Open access
PDF file
RAR. Alizadehsani
R. Alizadehsani
MRM. Roshanzamir
M. Roshanzamir
MAMoloud Abdar
Moloud Abdar
ABA. Beykikhoshk
A. Beykikhoshk
AKA. Khosravi
A. Khosravi
NSN. Sarrafzadegan
N. Sarrafzadegan
We present the coronary artery disease (CAD) database, a comprehensive resource, comprising 126 papers and 68 datasets relevant to CAD diagnosis, extracted from the scientific literature from 1992 and 2018. These data were collected to help advance research on CAD-related machine learning and data mining algorithms, and hopefully to ultimately advance clinical diagnosis and early treatment. To aid users, we have also built a web application that presents the database through various reports.

26 October 2021 in Clinical & Experimental Metastasis
Verified
Journal Article
Open access
PDF file
MPMaryam Panahiazar
Maryam Panahiazar
NCNolan Chen
Nolan Chen
DLDmytro Lituiev
Dmytro Lituiev
DHDexter Hadley
Dexter Hadley
In healthcare, artificial intelligence (AI) technologies have the potential to create significant value by improving time-sensitive outcomes while lowering error rates for each patient. Diagnostic images, clinical notes, and reports are increasingly generated and stored in electronic medical records. This heterogeneous data presenting us with challenges in data analytics and reusability that is by nature has high complexity, thereby necessitating novel ways to store, manage and process, and reuse big data. This presents an urgent need to develop new, scalable, and expandable AI infrastructure and analytical methods that can enable healthcare providers to access knowledge for individual patients, yielding better decisions and outcomes. In this review article, we briefly discuss the nature of data in breast cancer study and the role of AI for generating “smart data” which offer actionable information that supports the better decision for personalized medicine for individual patients. In our view, the biggest challenge is to create a system that makes data robust and smart for healthcare providers and patients that can lead to more effective clinical decision-making, improved health outcomes, and ultimately, managing the healthcare outcomes and costs. We highlight some of the challenges in using breast cancer data and propose the need for an AI-driven environment to address them. We illustrate our vision with practical use cases and discuss a path for empowering the study of breast cancer databases with the application of AI and future directions.

24 November 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
MPMaryam Panahiazar
Maryam Panahiazar
ABAndrew M. Bishara
Andrew M. Bishara
YCYorick Chern
Yorick Chern
RARoohallah Alizadehsani
Roohallah Alizadehsani
SISheikh M. Shariful Islam
Sheikh M. Shariful Islam
RBRamin E. Beygui
Ramin E. Beygui
Background: Women continue to have worse Coronary Artery Disease (CAD) outcomes than men. The causes of this discrepancy have yet to be fully elucidated. The main objective of this study is to detect gender discrepancies in the diagnosis and treatment of CAD.Methods: We used data analytics to risk stratify ~32,000 patients with CAD of the total 960,129 patients treated at the UCSF Medical Center over an 8 year period. We implemented a multidimensional data analytics framework to trace patients from admission through treatment to create a path of events. Events are any medications or noninvasive and invasive procedures. The time between events for a similar set of paths was calculated. Then, the average waiting time for each step of the treatment was calculated. Finally, we applied statistical analysis to determine differences in time between diagnosis and treatment steps for men and women.Results: There is a significant time difference from the first time of admission to diagnostic Cardiac Catheterization between genders (p-value = 0.000119), while the time difference from diagnostic Cardiac Catheterization to CABG is not statistically significant.Conclusion: Women had a significantly longer interval between their first physician encounter indicative of CAD and their first diagnostic cardiac catheterization compared to men. Avoiding this delay in diagnosis may provide more timely treatment and a better outcome for patients at risk. Finally, we conclude by discussing the impact of the study on improving patient care with early detection and managing individual patients at risk of rapid progression of CAD.

25 May 2022
Verified
Book Chapter
Open access
PDF file
MPMaryam Panahiazar
Maryam Panahiazar
YCYorick Chern
Yorick Chern
RRRamon Riojas
Ramon Riojas
OLOmar S. Latif
Omar S. Latif
ULUsha Lokala
Usha Lokala
RBRamin E. Beygui
Ramin E. Beygui
The development of an ontology facilitates the organization of the variety of concepts used to describe different terms in different resources. The proposed ontology will facilitate the study of cardiothoracic surgical education and data analytics in electronic medical records (EMR) with the standard vocabulary.

20 April 2021 in Research Square
Verified
Preprint
Open access
PDF file
MPMaryam Panahiazar
Maryam Panahiazar
ABAndrew M. Bishara
Andrew M. Bishara
YCYorick Chern
Yorick Chern
RARoohallah Alizadehsani
Roohallah Alizadehsani
JPJennifer Perri
Jennifer Perri
RBRamin Beygui
Ramin Beygui
Background: Cardiovascular Disease (CVD) and Coronary Artery Disease (CAD) in particular, is one of the leading causes of death, morbidity, and mortality in the United States. Notably, women continue to have worse outcomes than men. The causes of these discrepancies have yet to be fully elucidated. The main objective of this study is to detect gender discrepancies in outcome using data analytics to risk stratify ~ 32,000 patients with CAD of the total 960,129 patients treated at UCSF Medical Center during an eight years. As an implementation of clinical care, this study’s long-term goal is to improve precision diagnosis and ultimately management of CAD for both early detection and identification of patients at risk for rapid progression of the disease.Methods: We designed and implemented a multidimensional framework to trace patients from admission through treatment as a path of events. The time between events for a similar set of paths was calculated. Then the average waiting time for each step of the treatment was calculated for men and women. Finally, we applied statistical analysis to determine differences in time between diagnosis and treatment steps for men and women.Discussions: There were statistically significant gender-based differences in the common path of diagnosis and treatment of patients with CAD. The average time for women from the first visit to diagnostic Cardiac Catheterization was more than 2 months than for men (358.77 vs. 291.83 days). By contrast, the average time from diagnostic Cardiac Catheterization to treatment Cardiac Catheterization and Coronary Artery Bypass Grafting (CABG) was not significant. Women with CAD requiring revascularization have a significantly longer interval between their first physician encounter indicative of CVD and their first diagnostic cardiac catheterization compared to men. Avoiding the delay in diagnosis and treatment will provide a better outcome for patients at risk.